| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/23/2007 | US7166694 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells |
| 01/23/2007 | US7166568 Compositions and methods to inhibit formation of the C5b-9 complex of complement |
| 01/23/2007 | US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease |
| 01/23/2007 | US7166444 Nucleic acids encoding chromophores/fluorophores and methods for using the same |
| 01/23/2007 | US7166439 Assay for anti-INGAP antibodies |
| 01/23/2007 | US7166436 Compound for use as diagnostic tool in protein analysis |
| 01/23/2007 | US7166433 Purified nucleic acids encoding transmembrane cochlear-expressed genes; prognosticating and monitoring hearing loss; vectors, cell lines, monoclonal antibodies; genetic engineering |
| 01/23/2007 | US7166298 Genetic immunization with cationic lipids |
| 01/23/2007 | US7166295 Methods of treatment and diagnostic visualization, particularly in cancer |
| 01/23/2007 | US7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers |
| 01/23/2007 | US7166285 Anti-IL-12 antibodies and compositions |
| 01/23/2007 | US7166284 Completitive binding; immunoassay, immunotherapy |
| 01/23/2007 | US7166283 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 01/23/2007 | CA2326389C Novel cd19xcd3 specific polypeptides and uses thereof |
| 01/23/2007 | CA2187386C Gene encoding endo-.beta.-n-acetylglucosaminidase a |
| 01/18/2007 | WO2007008943A2 Optimized anti-ep-cam antibodies |
| 01/18/2007 | WO2007008933A2 Compositions and methods comprising complex alternative splice variants of myelin/oligodendrocyte genes (mogs) and antibodies directed thereto |
| 01/18/2007 | WO2007008712A2 Anti-alpha v beta 6 antibodies and uses thereof |
| 01/18/2007 | WO2007008697A2 Compositions and methods for refolding of denatured proteins |
| 01/18/2007 | WO2007008463A2 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 01/18/2007 | WO2007007160A2 Anti-madcam antibodies to treat fever |
| 01/18/2007 | WO2007007159A2 Anti-madcam antibodies to treat uterine disorders |
| 01/18/2007 | WO2007007151A2 Use of anti-mad-cam antibody for the treatment of emphysema |
| 01/18/2007 | WO2007007145A2 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 01/18/2007 | WO2007007086A2 Antibodies for anthrax |
| 01/18/2007 | WO2007006581A2 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/18/2007 | WO2007006101A1 Surface proteins of pasteurella multocida |
| 01/18/2007 | WO2006131953A3 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants |
| 01/18/2007 | WO2006125914A3 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 01/18/2007 | WO2006124689A3 Combination therapy |
| 01/18/2007 | WO2006117194A3 Gpr18 as a biomaker for th1 mediated immune response |
| 01/18/2007 | WO2006117193A3 Receptor in dendritic cells |
| 01/18/2007 | WO2006113308A8 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody |
| 01/18/2007 | WO2006110164A3 Deactivation of linking moieties in antibody-enzyme conjugates |
| 01/18/2007 | WO2006105954A3 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types |
| 01/18/2007 | WO2006088956A3 Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists |
| 01/18/2007 | WO2006081473A3 Methods for diagnosis and prognosis of epithelial cancers |
| 01/18/2007 | WO2006079565A3 Leishmania antigens suitable for a diagnostic kit of leishmania |
| 01/18/2007 | WO2006073748A3 Antibodies against antigen presenting cells and uses thereof |
| 01/18/2007 | WO2006072048A3 Compositions and methods for identifying modulators of hausp |
| 01/18/2007 | WO2006061723A3 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 01/18/2007 | WO2006026002A3 T cell receptors with enhanced sensitivity recognition of antigen |
| 01/18/2007 | WO2005120638A8 Combination of radio waves and pharmacologically active substances |
| 01/18/2007 | WO2005112564A3 Germline and sequence variants of humanized antibodies and methods of making and using them |
| 01/18/2007 | WO2005042695A3 Lipoparticles comprising proteins, methods of making, and using the same |
| 01/18/2007 | WO2004084837A3 Methods and compositions for treating and preventing inflammatory conditions |
| 01/18/2007 | WO2004048525A3 Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies |
| 01/18/2007 | US20070015913 Mrp3 genes and uses thereof |
| 01/18/2007 | US20070015907 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 01/18/2007 | US20070015704 Cancer drug target; useful in diagnostic, prophylactic, prognostic, of certain cancers |
| 01/18/2007 | US20070015700 Mammalian genes modulated during fasting and feeding |
| 01/18/2007 | US20070015250 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 01/18/2007 | US20070015247 Apolipoprotein receptor specific monoclonal antibody for use in the prevention and treatment of cell proliferative disorders |
| 01/18/2007 | US20070015244 System for antibody expression and assembly |
| 01/18/2007 | US20070015239 Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity |
| 01/18/2007 | US20070015228 Using anti-idiotypic antibody to determine CD20 concentration of cell; screening for modulators for prevention and/or treatment of HIV infection and cancer |
| 01/18/2007 | US20070015226 Method for detecting cancer using metal-oxide or metal-sulfide nanoparticle fluorescent material |
| 01/18/2007 | US20070015220 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015218 A Method for the Separation Anti-Amyloid Beta Antibody with Amyloid Beta Peptide |
| 01/18/2007 | US20070015217 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease |
| 01/18/2007 | US20070015215 Modified phycobilisomes and uses therefor |
| 01/18/2007 | US20070015211 Conformer-specific antibodies and method of use, thereof |
| 01/18/2007 | US20070015207 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis |
| 01/18/2007 | US20070015201 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 01/18/2007 | US20070015197 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 01/18/2007 | US20070015196 Growth factor with acts through Erb B-4 RTK |
| 01/18/2007 | US20070015173 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 01/18/2007 | US20070015163 Novel full-length cDNA |
| 01/18/2007 | US20070015150 Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland |
| 01/18/2007 | US20070015149 Prlz regulatory elements in the treatment of disease and the discovery of therapeutics |
| 01/18/2007 | US20070015140 Method of examining specimen and specimen container to be used in the examination method |
| 01/18/2007 | US20070014813 Immunogenic polypeptide comprising adjuvant (alum); coupled to diphtheria toxoid; diagnosis and treatment |
| 01/18/2007 | US20070014803 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 01/18/2007 | US20070014802 Modified antibody fragments |
| 01/18/2007 | US20070014800 Cytokine zalpha11 ligand antibodies |
| 01/18/2007 | US20070014799 Antibody and use of the same |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014796 Method for the production of non-immunogenic proteins |
| 01/18/2007 | US20070014794 preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras; yields of the heteromultimer over other unwanted end-products such as homomultimers |
| 01/18/2007 | US20070014793 Antibodies which activate an erythropoietin receptor |
| 01/18/2007 | US20070014790 Transcription control factor zhx3 |
| 01/18/2007 | US20070014789 Humanized antibody conjugates and related methods, assays, reagents, and kits |
| 01/18/2007 | US20070014787 71 human secreted proteins |
| 01/18/2007 | US20070014786 Methods for treating taxol-induced gut disorder |
| 01/18/2007 | US20070014785 Use of antibodies against CD20 for the treatment of the graft versus host disease |
| 01/18/2007 | US20070014724 inhibit the biological activity of multiple interferon (IFN) alpha subtypes but do not substantially inhibit the biological activity of IFN alpha 21, IFN beta or IFN omega; autoimmune diseases, transplant rejection and graft versus host disease; immunoconjugates |
| 01/18/2007 | US20070014720 Antibodies directed to CD20 and uses thereof |
| 01/18/2007 | CA2652434A1 Optimized proteins that target ep-cam |
| 01/18/2007 | CA2614320A1 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 01/18/2007 | CA2614314A1 Human anti-madcam antibodies |
| 01/18/2007 | CA2614183A1 Anti-alpha v beta 6 antibodies and uses thereof |
| 01/18/2007 | CA2613017A1 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 01/17/2007 | EP1744162A1 Cancer diagnosis and treatment using anti-robo1 antibody |
| 01/17/2007 | EP1743941A1 Novel mite allergen |
| 01/17/2007 | EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1743027A1 Mutant pneumolysin proteins |
| 01/17/2007 | EP1742969A2 Methods of identifying neoplasm-specific antibodies and uses thereof |
| 01/17/2007 | EP1742968A2 Il-13 mutein proteins, antibodies, compositions, methods and uses |